Radnor Capital Management LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 3,734 shares of the healthcare conglomerate’s stock, valued at approximately $1,795,000. UnitedHealth Group accounts for approximately 0.8% of Radnor Capital Management LLC’s holdings, making the stock its 29th largest holding.
Other institutional investors also recently added to or reduced their stakes in the company. Chelsea Counsel Co. purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $27,000. 25 LLC purchased a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $28,000. Cascade Investment Advisors Inc. purchased a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $28,000. Freedom Wealth Alliance LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $31,000. Finally, Kalos Management Inc. purchased a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $34,000. Institutional investors and hedge funds own 85.69% of the company’s stock.
Insider Transactions at UnitedHealth Group
In other news, CEO Andrew Witty sold 4,000 shares of the company’s stock in a transaction dated Wednesday, July 19th. The stock was sold at an average price of $506.19, for a total value of $2,024,760.00. Following the completion of the sale, the chief executive officer now owns 78,573 shares of the company’s stock, valued at $39,772,866.87. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.35% of the company’s stock.
UnitedHealth Group Price Performance
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings results on Friday, July 14th. The healthcare conglomerate reported $6.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.92 by $0.22. UnitedHealth Group had a return on equity of 26.72% and a net margin of 6.06%. The firm had revenue of $92.90 billion during the quarter, compared to the consensus estimate of $90.97 billion. During the same quarter in the previous year, the business earned $5.57 earnings per share. The firm’s quarterly revenue was up 15.6% compared to the same quarter last year. As a group, research analysts predict that UnitedHealth Group Incorporated will post 24.83 EPS for the current year.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Monday, September 11th will be given a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.55%. The ex-dividend date of this dividend is Friday, September 8th. UnitedHealth Group’s payout ratio is 33.65%.
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on the company. JPMorgan Chase & Co. lifted their price objective on UnitedHealth Group from $527.00 to $532.00 and gave the stock an “overweight” rating in a report on Monday, July 17th. Piper Sandler initiated coverage on UnitedHealth Group in a report on Thursday, May 25th. They set an “overweight” rating and a $580.00 price objective for the company. StockNews.com initiated coverage on UnitedHealth Group in a report on Thursday, August 17th. They issued a “buy” rating for the company. Wells Fargo & Company cut their price target on UnitedHealth Group from $616.00 to $561.00 in a report on Thursday, July 13th. Finally, Stephens reissued an “overweight” rating and issued a $560.00 price target on shares of UnitedHealth Group in a report on Friday, August 11th. Two investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $575.65.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
- Five stocks we like better than UnitedHealth Group
- How to Invest in Blockchain Stocks Step by Step
- 5 Reasons Apple’s New Phone Moves the Needle: 5 That It Won’t
- Trading Stocks: RSI and Why it’s Useful
- MarketBeat Week in Review – 9/11 – 9/15
- How to Use High Beta Stocks to Maximize Your Investing Profits
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.